Murine study reveals that neutrophil Thbs1 signaling via epithelial CD36 promotes mucosal barrier breakdown during ischemia-reperfusion, highlighting a therapeutic target for shock.
Background Intestinal barrier failure following ischemia–reperfusion (IR) injury is a critical event that drives lethal systemic complications; however, the specific intercellular signals governing epithelial cell fate under these pathological conditions remain incompletely understood. Methods We performed single-cell RNA sequencing (scRNA-seq) on intestinal tissues from a murine IR model to map intercellular communication networks. The identified ligand–receptor pair was functionally validated using neutrophil-specific thrombospondin-1 (Thbs1) knockout mice, combined with pharmacological inhibition and activation of CD36, as well as biochemical and histological analyses. Results scRNA-seq analysis of the IR-injured gut revealed a key neutrophil–epithelial signaling pathway mediated by the Thbs1–CD36 ligand–receptor pair. Neutrophil-specific genetic ablation of Thbs1 markedly attenuated IR-induced epithelial apoptosis and barrier disruption. Mechanistically, Thbs1 binding to epithelial CD36 activated JNK signaling, mediating a proapoptotic cascade. CD36 inhibition was protective, whereas its activation bypassed the requirement for Thbs1 and provoked mucosal injury. Conclusions Our study elucidates a key mechanism of gut barrier failure and identifies the Thbs1–CD36–JNK axis as a promising therapeutic target for mitigating intestinal IR injury in critical conditions such as burns and shock.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: